Zepbound tops Wegovy for weight loss in study comparing the drugs
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.
Watch CBS News
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.
New research suggests diabetes drugs like Ozempic, which some people also take to lose weight, may also help patients suffering from substance addiction. CBS News contributor Dr. Celene Gounder has more.
A new study shows diabetes drugs like Mounjaro and Ozempic, which people also take to lose weight, may help patients suffering from addiction. CBS News contributor Dr. Celine Gounder explains.
While it may seem like everyone is taking Ozempic, not everyone can afford to. The high price of popular diabetes drugs prevents many people from getting them.
Ozempic and other GLP-1 RA drugs, including Wegovy, Mounjaro and Zepbound, are being scrutinized.